Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1Lymphoid 1

Conditions

Breast Neoplasms 931Neoplasms 705Prostatic Neoplasms 487Lung Neoplasms 390Colorectal Neoplasms 359Carcinoma, Non-Small-Cell Lung 356Leukemia, Myeloid, Acute 278Pancreatic Neoplasms 233Brain Neoplasms 223Neoplasm Metastasis 221Multiple Myeloma 214Carcinoma, Hepatocellular 199Head and Neck Neoplasms 185Precursor Cell Lymphoblastic Leukemia-Lymphoma 180Glioblastoma 180Melanoma 173Ovarian Neoplasms 167Squamous Cell Carcinoma of Head and Neck 158Recurrence 143Rectal Neoplasms 142Uterine Cervical Neoplasms 140Sarcoma 134Hematologic Neoplasms 131Glioma 128Stomach Neoplasms 127Triple Negative Breast Neoplasms 126Carcinoma, Renal Cell 123Esophageal Neoplasms 109Colonic Neoplasms 109Myelodysplastic Syndromes 107

Interventions

pegaspargase 1Methylprednisolone 1Etoposide 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphohistiocytosis, Hemophagocytic × 90 days × Clear all
NCT07525466 2026-04-13

Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH)

Beijing Tongren Hospital

Phase 1/2 Recruiting
25 enrolled
LymphoidMyeloid

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡